Trial Profile
Comparison between indacaterol and tiotropium on respiratory function and exercise tolerance in COPD patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 02 Jun 2013 Status changed from recruiting to completed, based on presentation of results.
- 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
- 02 Jul 2012 New trial record